首页 | 本学科首页   官方微博 | 高级检索  
检索        

盐酸二甲双胍缓释胶囊在健康人体的生物等效性研究
引用本文:赵志刚,李嘉静,杨莉,赵秀丽,王淑民,李冬梅,孙运强.盐酸二甲双胍缓释胶囊在健康人体的生物等效性研究[J].中国药学杂志,2006,41(20):1579-1582.
作者姓名:赵志刚  李嘉静  杨莉  赵秀丽  王淑民  李冬梅  孙运强
作者单位:1. 北京天坛医院药剂科,北京,100050
2. 北京同仁医院药剂科,北京,100730
摘    要: 目的研究盐酸二甲双胍缓释胶囊的药动学和相对生物利用度。方法20名健康男性志愿者随机、交叉单剂量和多剂量口服盐酸二甲双胍缓释胶囊和普通片1 000 mg,采用高效液相色谱法测定其血药浓度,计算各药动学参数和相对生物利用度。结果20名健康志愿者单次po盐酸二甲双胍缓释片和普通片1 000 mg的主要药动学参数ρmax分别为:(1.27±0.32)和(1.82±0.32)mg·L-1;tmax分别为(5.0±1.62)和(2.95±0.72)h;AUC0~t(13.53±3.87)和(12.36±2.24)mg·h·L-1;AUC0~∞(14.44±4.09)和(12.66±2.34)mg·h·L-1,相对生物利用度(F)为(109.62±26.81)%。多次po盐酸二甲双胍缓释胶囊和普通片的主要药动学参数分别为:ρmin(0.10±0.05)和(0.33±0.09)mg·L-1;AUCss(12.28±2.73)和(8.59±2.01)mg·h·L-1;DF(239.68±30.98)%和(118.68±22.34)%,相对生物利用度(F)为(72.82±11.37)%。结论AUC经方差分析和双单侧t检验,两制剂具有生物等效性。ρmax经检验不具等效性,tmax经非参数检验有显著性差异(P<0.05),受试缓释胶囊较参比普通片的ρmax小、tmax有所延长,表明受试制剂具有缓释特性。

关 键 词:盐酸二甲双胍  缓释胶囊  生物等效性  高效液相色谱法
文章编号:1001-2494(2006)20-1579-04
收稿时间:2005-09-12
修稿时间:2005-09-12

Study on Pharmacokinetics and Relative Bioavailability of Metformin Hydrochloride Sustained Release Capsule in Healthy Volunteers
ZHAO Zhi-gang,LI Jia-jing,YANG Li,ZHAO Xiu-li,WANG Shu-min,LI Dong-mei,SUN yun-qiang.Study on Pharmacokinetics and Relative Bioavailability of Metformin Hydrochloride Sustained Release Capsule in Healthy Volunteers[J].Chinese Pharmaceutical Journal,2006,41(20):1579-1582.
Authors:ZHAO Zhi-gang  LI Jia-jing  YANG Li  ZHAO Xiu-li  WANG Shu-min  LI Dong-mei  SUN yun-qiang
Institution:1.Department of Pharmacology,Beijing Tiantan Hospital,Beijing 100050,China;2. Department of Pharmacology,Beijing Tongren Hospital,Beijing 100730,China
Abstract:OBJECTIVE To study pharmacokinetics and relative bioavailability of metformin hydrochloride sustained release capsule in healthy volunteers.METHODS The serum concentrations of 20 volunteers were determined by HPLC after a single and multiple oral doses of 1 000 mg of metformin hydrochloride capsule or reference metformin hydrochloride tablet in a randomized crossover design study.The pharmacokinetic parameters were calculated and the relative bioavailability and bioequivalence of two formulations were evaluated.RESULTS The pharmacokinetic parameters for test and reference drugs after a single oral dose were as follows:ρmax(1.27±0.32) and(1.82±0.32)mg·L-1;tmax(5.0±1.62)and(2.95±0.72)h;AUC0~t(13.53±3.87)and(12.36±2.24) mg·h·L-1;AUC0~∞(14.44±4.09) and(12.66±2.34) mg·h·L-1,respectively.The relative bioavailability of the test preparation was(109.62±26.81)%.The pharmacokinetic parameters for test and reference preparations after multiple oral doses were as follows:ρmin(0.10±0.05) and(0.33±0.09)mg·L-1;AUCss(12.28±2.73) and(8.59±2.01) mg·h·L-1;DF(239.68±30.98)% and(118.68±22.34)%.The relative bioavailability was(72.82±11.37)%. CONCLUSION The ρmax of metformin sustained release capsules is lower and tmax is longer than those of regular ones.The results indicate that two formulations are bio-equivalent.
Keywords:metformin hydrochloride  sustained release capsule  bio-equivalent  HPLC
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号